Millipore Sigma Vibrant Logo

25972 2-Deoxy-D-glucose - CAS 154-17-6 - Calbiochem

Non-metabolizable derivative of glucose that can be carried by the glucose carrier in human erythrocytes. An indirect inhibitor of hexokinase. Reported to reduce the incidence of doxorubicin-induced apoptosis.

2-Deoxy-D-glucose - CAS 154-17-6 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
View Products on Sigmaaldrich.com
25972
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
154-17-6C₆H₁₂O₅

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
25972-1GM
Retrieving availability...
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Botol kaca 1 gm
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewNon-metabolizable derivative of glucose that can be carried by the glucose carrier in human erythrocytes. An indirect inhibitor of hexokinase. Reported to reduce the incidence of doxorubicin-induced apoptosis.
      Catalogue Number25972
      Brand Family Calbiochem®
      References
      ReferencesThakkar, N.S., and Potten, C.S. 1993. Cancer Res. 53, 2057.
      Product Information
      CAS number154-17-6
      FormOff-white to white powder
      Hill FormulaC₆H₁₂O₅
      Chemical formulaC₆H₁₂O₅
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSMQ3325000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      25972-1GM 04055977217445

      Documentation

      2-Deoxy-D-glucose - CAS 154-17-6 - Calbiochem MSDS

      Title

      Safety Data Sheet (SDS) 

      2-Deoxy-D-glucose - CAS 154-17-6 - Calbiochem Certificates of Analysis

      TitleLot Number
      25972

      References

      Reference overview
      Thakkar, N.S., and Potten, C.S. 1993. Cancer Res. 53, 2057.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-April-2008 RFH
      DescriptionNon-metabolizable derivative of glucose that can be carried by the glucose carrier in human erythrocytes. An indirect inhibitor of hexokinase. Reported to reduce the incidence of doxorubicin-induced apoptosis.
      FormOff-white to white powder
      CAS number154-17-6
      RTECSMQ3325000
      Chemical formulaC₆H₁₂O₅
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (5 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C.
      Toxicity Standard Handling
      Merck USA index14, 2904
      ReferencesThakkar, N.S., and Potten, C.S. 1993. Cancer Res. 53, 2057.